Aswin, S. 2002. Biologi Molekuler Kematian Sel Terprogram

Daftar Postaka

Akca, H., Ozes, O. 2002a. Antitumor Effects of TNF-P, 5-FU and TheirCombinations on Cervical Carcinoma Cell Lines. Turk J Med Sci 32*127-132.

Akca, H., Ozes, O. 2002b. Hydroxyurea Induces p53 Accumulation andApoptosis in Human Cervical Carcinoma Cells. TurkJBiol 26: 45-150.

Al-Mondhiry, H. 1984. Calanone, A Novel Coumarin from C. testimamii. Am JHematol 16:193-202.

Ali, A. 2004. Pengaruh Fraksi KJoroform Ekstrak Buah Brucea Javanica (L.) Men.(Buah Makassar) Terhadap Sitotoksisitas, Aktivitas Proliferasi, dan EksprcsiGen p53 pada Sel Raji Terinfeksi Epstein Ban Virus dan HeLa TerinfeksiHuman Papilloma Virus (HPV). Tesis. Program Pascasaijana UniversitasGadjah Mada Yogyakarta.

Angerer, E.; Kager, M., Kervin, K., Benefield, C., Umerane, A., Albainy-Jenei,Zhao, Q.S., and Khazaeli, M.B. 1994. J Can Res Clin Oncol 120 (suppi):S3-S10.

Aswin, S. 2002. Biologi Molekuler Kematian Sel Terprogram. Naskah LengkapPertemuan Ilmiah Tahunan Ilmu Penyakit Dalam FK UGM, Natour Garuda,13-14 September, Yogyakarta.

Baguley, B.C. 2002. A Brief History of Cancer Chemotherapy in Z)rwgDevelopment, Academic Press, Oxford, United Kingdom.

Berkada, B., H. Bouffard-Byubaglu, dan U. Derman. 1983. Agents Actions. JCarcinogen 13(1): 50-51.

Budd, R.C. 2002. Death Receptors Couple to Both Cell Proliferation andApoptosis. JClin Invest 109 : 437-442.

Bunz, F., Hwang, P.M., Torrance,C., Waldmann, T., Zhang, Y., Dillehay, L.,Williams, J., Lengauer, C., Kinzler, K.W., and Vogelstein, B. 1999.Disruption of p53 in human cancer cells alters the responses to therapeuticagents. JClin Invest 104 (3):263-269.

Budzisz, E., Brze2inska,E., Krajewska, U., and Rozalski, M. 2003. CytotoxicEffects, Alkylating Properties and Molecular Modelling of CoumarinDerivates and Their Phosphonic Analogues. EurJMedChem 38:597-603.

92

Uji aktifitas sitotoksik senyawa kalanon dan 2,4-dinitrofenilhidrazon kalanon pada sel hela danpengaruhnya terhadap ekspresi gen P53 dan protein P21EKOWATI, Heny, Dr. Med. dr. Indwiani AstutiUniversitas Gadjah Mada, 2008 | Diunduh dari http://etd.repository.ugm.ac.id/

Chasani, M. 2002. Sintesis Senyawa Tuninan Kalanon dan Uji AktivitasBiologinya. Tesis. Program Pascasaijana Universitas Indonesia, Jakarta.

Corwin, E.J. 2008. Handbook of Pathophysiology, 3"* Edition, LippincottWilliams & Wilkins, Philadelphia, USA.

Chrysomali, E., Nikitakis, N.G., Tosios, K., Sauk, J.J., Papanicolaou, S.I. 2003.Immunohistochemical Evaluation of Cell Proliferation Antigen K1-67 andapoptosis-related Protein Bcl-2 and caspase-3 in oral Granular Cell Tumor.Oral Surg Oral Med Oral Pathol Oral Radiol Endo 96:566-572.

Chuang, J.Y., Huang, Y.F., Lu, H.F., Ho, H.C., Yang, J.S., Li, T.M., Chang, N.W.,and Chung, J.G. 2007. Coumarin induces cell cycle arrest and apoptosis inhuman cervical cancer HeLa cells through a mitochondria- and caspase-3dependent mechanism and NF-kappaB down-regulation. In vivo21(6): 1003-9.

Chu E, Koeller DM, Johnston PG, Zinn S, Allegia CJ.1993. Regulation ofthymidylate synthase in human colon cancer cells treated with 5-fluorouraciland interferon-gamma. Mol Pharmacol 43: 527 - 533.

Denny, W.A. 2002. The Contribution of Synthetic Organic Chemistry toAnticancer Drug Development in Anticancer Drug Development, AcademicPress, Oxford, United Kingdom.

Departemen Kesehatan. 2007. Indonesia Health Profile 2005. Jakarta, Indonesia

Else!, D., Fergh, G., Fischer, B., Manzow, S., and Schmeig, K. (Eds). 2000. Guideto Cell Proliferation and Apoptosis Methods. Roche Diagnostic Corporation,USA, pp 24-26. 36-38.

El-Deiry, W., Tokino, T., Velculescu, V.. Levy, D., Parson, S.R., Trent, J., Lin, D.,Mercer, W.E., Kinzler, K., and Vegelstein, B. 1993. WAFI a PotentialMediator of p53 Tumor Suppression. Cell 75:817-825.

Freshney, R.L 2000. Culture ofAnimal Cells a Manual of basic Technicques, 4***ed., Wiley-Lies, Canada.

Ghadek W.J., Kotala, V., Kuchtickovas, M.D., Horky. 2002. Induction ofApoptosis in Human Servik Carsinoma Cell During Therapy by Cisplatin,presented at the International Symposium on Predictive Oncology andIntervention Strategies; Paris. France; February 9 - 12, 2002; in the sectionon Apoptosis - Molecular Mechanisms.

Cartel, A.L., Serfas M.S., Tyner A.L. 1996. p21 Negative Regulator of The CellCyoXe.ProcSocExpBiolMed. 2X2: 138- 149.

93


Harris, C.C. and Holstein, M. 1993. Clinica: Implications of the p53 TumorSuppesor Gen. NEngJMed 329: 1318-27.

Hupp,T.R., Lane, D.P., and Ball, K.L. 2002, Strategies for manipulating the p53pathway in the treatment of human cancer. BiochemJ352: 1-17.

Iswanto. P., Chasani, M. dan Vaulina, E. 2007. Sintesis Senyawa TurunanKalanon sebagai Zat Antileukemia dengan Pendekatan QSAR {QuantitativeStructure-Activity Relationship). Laporan Penelitian Lemlit UNSOLD.

Kastan, M. B.and Skapek, S. X. 2001. Molecular Biology of Cancer : The CellCycle in Cancer Principle & Practice of Oncology. Ed 6'*', Eds. DeVita,V.T., Hellman, S.,and Rosenberg, S.A. , pp. 91-102, Lippicott Williams&Wilkins, Philadelphia.

King, R.J.B. 2000. Career Biologi. Ed 2°^, Pearson Education Limited, England,pp. 1-7.

Kostova, 1. 2005. Synthetic and Natural Coumarins as Cytotoxic Agents, CurrMed Chem - Anti-Cancer Agents 5:29-46.

Kubbutat, M.H.G., Ludwig, R.L., Ashcroft, M., and Vousden, K.H. 1998.Regulation of Mdm2-directed Degradation by the C- Terminus of p53. MolCellBiol 18 (10): 5690-5698.

Lane, O.P., Crawford, L.V. 1979. T Antigen is Bound to Host Protein in SV40Transformed Cells. Nature 278:261-3.

Liotta, L.A. and Liu, E.T. 2001, Essensial of Molecular Biology: Genomic andCancer in Cancer Principle Practice of Oncology. Ed 6* Eds. DeVita,V.T., Hellman, S.,and Rosenberg, S.A., Lippicott Williams &Wilkins,Philadelphia

MacKay, H.T., 2006, Gynecology in Current Medical Diagnosis and Treatment,45^'' Edition, Eds. Tiemey, Lawrence M., McPhee, Stephen J., Papadakis,Maxie A., McGraw-Hill, Publishing Company, New York.

Mc. Culloch, P and George, E.D. 1988. Coumarin Derivatives Inhibition. BrJournal Cancer 5%: 158-162.

Mosmann, T.1983. Rapid Colorimetric Assay for Cellular Growth and Survival:Application to Proliferation and Cytotoxicity Assays. J Immunol Meth 65:55-63.

Mudasir, Tahir, I., dan Putri, I.P.A.M. 2003. Analisis Hubungan Kuantitatif antaraStruktur dan Afctivitas Fungisida Turunan 1,2,4-ThiadazoIin Berdasarkan

94


Parameter Molekular Hasil Perhitungan Metode AMI. IruJo J Chem 3(1).39-47.

Muranaka, K. 2001. Anticancer Activity of Estradiol Derivates: A QuantitativeStructure-Activity Relationship Approach. JCkem 78 : 1390 - 1393.

Nicolantonio FD, Mercer SJ, Knight LA, Gabriel FG, Whitehouse PA, Sharma S,Fernando A, Glaysher S, Palma SD, Johnson P, Somers SS, Toh S, Higgins B,Lamont A, Gulliford T, Hurren J, Yiangou C, and Cree lA. 2005. Cancer celladaptation to chemotherapy. BMC Cancer 5:78.

Nogrady, T. 1992. Kimia Medisinal: Pendekatcm secara Biokimia, teijemahan olehRaslim R. Penerbit ITB. Bandung.

Nussbaum, R.L., Mcinnes, R.R. and Willard, H.F. 2001. Genetics and Cancer inThompson <& Thompson Genetics in Medicine . Ed 6'*', Eds. Thompson,M.W., Mcinnes R.R., and Willard, H.F.pp. 311-332, W.B. SaundersCompany, USA.

Pae, H.-0., Oh, H., Yun, Y.-G, Oh, G.-S,Jang, S.I., Hwang, K.-M, Kwan, T.-O.,Lee, H.-S, and Chung, H.-T. 2002. Imperatorin, a Furanocoumarin fromAngelica dahurica (Umbelliferae), Induces Cytochrome c-DependentApoptosis in Human Promylocytic Leukaemia, HL-60 Cells. PharmacolToxicol 91 (I):40.

Pan, J., Xu, G., and Yeung, S.-C.J. 2001. Cytochrome c Release is Upstream toActivation of Caspase-9, Caspase-8, and Caspase-3 in the EnhancedApoptosis of Anaplastic Thyroid Cancer Cells Induced by Manumycin andPaclitaxel. yC///i£«dbcn>M)/ Metab 86:4731-4740.

Pommier, Y., Yu,Q., Kohn, K.W. 2002, Novel Target In the Cell Cycle and CellCycle Ceckpoints in Anticancer Drug Development, Academic Press,Oxford, United Kingdom.

Pranowo, H. D. 2002. Pengantar Kimia Komputasi. Austrian-Indonesian Centrefor Computational Chemistry (AIC), Jurusan Kimia Fakultas MIPAUniversitas Gadjah Mada, Yogyakarta.

Rang, H.P., Dale, M.M., Ritter, J..M. and Moore, P.K.. 2003. CancerChemotherapy in Pharmacology. Ed 5*^, Eds. Hunter, L. pp. 693-707,Churchill Livingstone Elsevier Science Limited, United Kingdom.

Rode, H.D., Eisel, D.. Frost, I. 2004. Apoptosis, Cell Death and Cell ProliferationManual. 3 ed. Roche Applied Science, USA.

95


Rugo, H.S., 2006, Cancer in Current Medical Dia^wsis and Treatment^ 45***Edition, Eds. Tiemey, Lawrence M., McPhee, Stephen J., Papadakis, MaxieA., McGraw-Hill, Publishing Company, New Yorl^ USA.

Rose, P. G., 2006, Concurrent chemoradiation for locally advanced carcinoma ofthe cervix: where are we in 2006? Annals ofOncology 17 (Supplement 10):x224-x229.

Siswandono, Soekardjo, B. 1998. Prinsip-Prinsip Rancangan Obat, CetakanPertama. Airlangga University Press. Surabaya.

Stetler-Stevenson, W.G., Kleiner, D.E. 2001. Molecular Biology of Cancer :Invasion and Metastases in Cancer Principle & Practice of Oncology. Ed6*, Eds. DeVita, V.T., Hellman, S.,and Rosenberg, S.A. , pp. 91-102,Lippicott Williams &Wilkins, Philadelphia, USA.

Swain SM, Lippman ME, Egan EF, Drake JC, Steinberg SM , AHegra CJ. 1989.Fluorouracil and high-dose leucovorin in previously treated patients withmetastatic breast cancer. JClin Oncol 7:890-899.

Sukardja, I.D.G. 2000. Onkologi Klinik. Airlangga University Press, Surabaya.

Stoklosa,T. and Golab, J. 2005 Prospects for p53-based cancer therapy. ActaBiochimica Polonica 53 (2):321-328.

S2ymanska, K. and Hainaut, P. 2003. P53 and mutations in human cancer. ActaBiochimica Polonica 50 (1): 231-238.

Szewczyk, A. & Wojtezak, L. 2002. Mitochondria as A Pharmacological Target.Pharmacol Rev 54: 101 - 127.

Tjindarburai, D., and Mangunkusumo, R.. 2002. Cancer in Indonesia, Present andFuture, JprtJ Clin Oncol., 32 (Supplement 1); S17-S21.

Talapatra, S. and Thompson, C.B. 2001. Growth Factor Signaling in CellSurvival: Implications for Cancer Treatment. J Pharmacol Exp Ther 298 •873-878.

Utoro, T. 2002. Kematian sel Terprogram (Apoptosis). Pertemuan IlmiahTahunan Ilmu Penyakit Dalam FK UGM, Natour Garuda, 13 September,Yogyakarta.

Wang, X., 2001. The Expanding Role of Mitochondria in Apoptosis. GenesDevelopm 15: 2922 - 2933.

Wibisono, L. K. 1997. Penentuan Struktur Molekul Derivat Kumarin dari KulitBatang C biflorum Hend & WS dan Pengaruhnya terhadap Pertumbuhan in

96


vivo Tumor Kelenjar Susu Mencit C3H. Tests, Magister Sains Ilmu KimiaUniversitas Indonesia, Jakarta,

Yin, L., Ohno, T., Weichselbaum, R., Kharbanda, S., and Kufe, D. 2001. TheNovel Isocoumarin 2-(8-Hydroxy-6-methoxy-l-oxo-l/J-2-benzopyran- 3-yI)Propionic Acid (NM-3) Induces Lethality of Human Carcinoma Cells byGeneration of Reactive Oxygen Species. Molecular Cancer Therapeutics 1:43-48.

Young, R.C. 2004. Gynecologic Malignancies in Harrison's Principles ofInternal Medicine, 16*^ Edition, McGraw- Hill, Publishing Company, NewYork, USA.

Zhang, J.-X, Fong, W.-F., Wu, J.Y.-C, Yang, M., and Cheung, H.-Y.2003.Pj^ranocoumarins Isolate from Peucedanum praeruptorum as DifferentiationInducers in Human Leukemic HL-60 Cells. Planta Med 69: 223-229.

Zeiss, C.J. 2003. The Apoptosis-Necrosis Continuum: Insights from GeneticallyAltered Mice. Vet Pathol 40: 481-495.

97


Documents

Aswin, S. 2002. Biologi Molekuler Kematian Sel Terprogram